Life Scientist > Health & Medical

Coeliac disease related to diabetes

22 March, 2010 by Staff Writers

An international research team has identified new gene variants associated with gluten intolerance.


Positive results for Specialised Therapeutics Australia in lung cancer trial

18 March, 2010 by Tim Dean

Phase III trial shows breast cancer drug, Abraxane, effective against lung cancer.


Personalised medicine advanced with TGA approval of bowel cancer treatment

10 March, 2010 by Tim Dean

Metastatic bowel cancer treatment, Erbitux, is one of the new generation of highly effective personalised medicine therapies.


Diabetes market growing, obesity market shrinking: analysts

10 March, 2010 by Tim Dean

Datamonitor Group predicts antidiabetics market will continue to expand, but obesity plagued by perception and treatment issues.


Link found between Hepatitis C and diabetes

09 March, 2010 by Staff Writers

Researchers at the Garvan Institute of Medical Research found that individuals with Hepatitis C are more likely to develop diabetes.


Feature: Appetite for NPY

01 March, 2010 by Tim Dean

A better understanding of neuropeptide Y could lead to new therapeutics to treat obesity. Herbert Herzog gives some insights in to this complex system.


Epilepsy, aging and malaria research big winners in 2010 NHMRC grants

25 February, 2010 by Staff Writers

$102 million in NHMRC grants target epilepsy, malaria, melanoma, pain, infant health, medical tests, infection, aging, Indigenous health and stuttering.


Patrys granted key patent for lead anti-cancer product

24 February, 2010 by Staff Writers

Issued patent for lead product PAT-CM1 provides protection through the year 2023.


MicroRNA causes "double whammy" of metastasis and angiogenesis in breast cancer

23 February, 2010 by Tim Dean

New research shows the microRNA, miR-9, plays a significant role in metastasis and blood vessel growth in breast cancer and could provide a target for future therapies.


Epigenetics makes cancer cell "lean mean machine"

22 February, 2010 by Tim Dean

Garvan researchers find gene silencing in prostate cancer is more substantial than expected and could provide key to battling cancer.


Step forward in linking metals to Alzheimer’s disease

17 February, 2010 by Staff Writers

Study in mice finds significant role for zinc transport protein ZnT3 in the neurodegenerative disease.


Lorne special: Sleuthing oncogenes

16 February, 2010 by Graeme O'Neill

Tom Gonda’s research team at the Diamantina Institute in Brisbane is using new technology to unmask the proto-oncogenes that can cause cancer in mutant form.


Lorne special: Piecing together the breast cancer puzzle

15 February, 2010 by Fiona Wylie

Just when things seemed to be going around in circles, some quite unexpected data from WEHI has opened up an exciting new avenue in breast cancer research.


Lorne special: Mortality, metastasis and miRNAs

12 February, 2010 by Graeme O'Neill

Greg Goodall’s Adelaide research group has explored found tantalising links between the miR-200 gene family and metastasis in a wide range of cancers.


Lorne special: Dynamic dynamin and synaptic transmission

09 February, 2010 by Fiona Wylie

Dynamin-1, plays a key role in the endocytosis at the synapse and the activity of neurotransmitters. Professor Phil Robinson is revealing the behaviour of this pivotal protein and its role in diseases like epilepsy.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd